Quantitatively controlling expression of miR-17∼92 determines colon tumor progression in a mouse tumor model

American Journal of Pathology

Volumn 184, Issue 5, 2014, Pages 1355-1368

  Jiang, Hong ^a,b,c,d   Wang, Ping ^e   Wang, Qilong ^b   Wang, Baomei ^b   Mu, Jingyao ^b   Zhuang, Xiaoying ^b   Zhang, Lifeng ^b   Yan, Jun ^b   Miller, Donald ^b   Zhang, Huang Ge ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c University of Louisville School of Medicine   (United States)

^d THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^e WUHAN INSTITUTE OF VIROLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; MICRORNA; MIRNA 17; MIRNA 18A; MIRNA 92; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG; MIRN17-92 MICRORNA, MOUSE; MIRN18 MICRORNA, MOUSE; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL LINE; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE; LUCIFERASE ASSAY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; WNT SIGNALING PATHWAY; ANIMAL; BAGG ALBINO MOUSE; COLON TUMOR; DISEASE COURSE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; GENOME; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; BASE SEQUENCE; BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TARGETING; GENOME; HUMANS; MICE, INBRED BALB C; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; WNT PROTEINS;

EID: 84899542912     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.01.037     Document Type: Article

References (49)

1. G. Hutvagner, J. McLachlan, A.E. Pasquinelli, E. Balint, T. Tuschl, and P.D. Zamore A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA Science 293 2001 834 838
2. J. Han, Y. Lee, K.H. Yeom, J.W. Nam, I. Heo, J.K. Rhee, S.Y. Sohn, Y. Cho, B.T. Zhang, and V.N. Kim Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex Cell 125 2006 887 901
3. B.P. Lewis, C.B. Burge, and D.P. Bartel Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 120 2005 15 20
4. S. Volinia, G.A. Calin, C.G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, R.L. Prueitt, N. Yanaihara, G. Lanza, A. Scarpa, A. Vecchione, M. Negrini, C.C. Harris, and C.M. Croce A microRNA expression signature of human solid tumors defines cancer gene targets Proc Natl Acad Sci U S A 103 2006 2257 2261
5. L. Poliseno, L. Salmena, J. Zhang, B. Carver, W.J. Haveman, and P.P. Pandolfi A coding-independent function of gene and pseudogene mRNAs regulates tumour biology Nature 465 2010 1033 1038
6. N. Yamamichi, R. Shimomura, K. Inada, K. Sakurai, T. Haraguchi, Y. Ozaki, S. Fujita, T. Mizutani, C. Furukawa, M. Fujishiro, M. Ichinose, K. Shiogama, Y. Tsutsumi, M. Omata, and H. Iba Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development Clin Cancer Res 15 2009 4009 4016
7. P. Wang, F. Zou, X. Zhang, H. Li, A. Dulak, R.J. Tomko Jr., J.S. Lazo, Z. Wang, L. Zhang, and J. Yu microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells Cancer Res 69 2009 8157 8165
8. J. Lu, G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B.L. Ebert, R.H. Mak, A.A. Ferrando, J.R. Downing, T. Jacks, H.R. Horvitz, and T.R. Golub MicroRNA expression profiles classify human cancers Nature 435 2005 834 838
9. L. He, J.M. Thomson, M.T. Hemann, E. Hernando-Monge, D. Mu, S. Goodson, S. Powers, C. Cordon-Cardo, S.W. Lowe, G.J. Hannon, and S.M. Hammond A microRNA polycistron as a potential human oncogene Nature 435 2005 828 833
10. P. Mu, Y.C. Han, D. Betel, E. Yao, M. Squatrito, P. Ogrodowski, E. de Stanchina, A. D'Andrea, C. Sander, and A. Ventura Genetic dissection of the miR-17∼92 cluster of microRNAs in Myc-induced B-cell lymphomas Genes Dev 23 2009 2806 2811
11. V. Olive, M.J. Bennett, J.C. Walker, C. Ma, I. Jiang, C. Cordon-Cardo, Q.J. Li, S.W. Lowe, G.J. Hannon, and L. He miR-19 is a key oncogenic component of mir-17-92 Genes Dev 23 2009 2839 2849
12. Z. Yu, C. Wang, M. Wang, Z. Li, M.C. Casimiro, M. Liu, K. Wu, J. Whittle, X. Ju, T. Hyslop, P. McCue, and R.G. Pestell A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation J Cell Biol 182 2008 509 517
13. M. Dews, A. Homayouni, D. Yu, D. Murphy, C. Sevignani, E. Wentzel, E.E. Furth, W.M. Lee, G.H. Enders, J.T. Mendell, and A. Thomas-Tikhonenko Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster Nat Genet 38 2006 1060 1065
14. Z. Yu, N.E. Willmarth, J. Zhou, S. Katiyar, M. Wang, Y. Liu, P.A. McCue, A.A. Quong, M.P. Lisanti, and R.G. Pestell microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling Proc Natl Acad Sci U S A 107 2010 8231 8236
15. G. Eiriksdottir, G. Johannesdottir, S. Ingvarsson, I.B. Björnsdottir, J.G. Jonasson, B.A. Agnarsson, J. Hallgrimsson, J. Gudmundsson, V. Egilsson, H. Sigurdsson, and R.B. Barkardottir Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis Eur J Cancer 34 1998 2076 2081
16. A. Stembalska, N. Blin, D. Ramsey, and M.M. Sasiadek Three distinct regions of deletion on 13q in squamous cell carcinoma of the larynx Oncol Rep 16 2006 417 421
17. X.L. Zhang, W.L. Fu, H.X. Zhao, L.X. Zhou, J.F. Huang, and J.H. Wang Molecular studies of loss of heterozygosity in Chinese sporadic retinoblastoma patients Clin Chim Acta 358 2005 75 80
18. Y.W. Lin, J.C. Sheu, L.Y. Liu, C.H. Chen, H.S. Lee, G.T. Huang, J.T. Wang, P.H. Lee, and F.J. Lu Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions Eur J Cancer 35 1999 1730 1734
19. L. Zhang, J. Huang, N. Yang, J. Greshock, M.S. Megraw, A. Giannakakis, S. Liang, T.L. Naylor, A. Barchetti, M.R. Ward, G. Yao, A. Medina, A. O'Brien-Jenkins, D. Katsaros, A. Hatzigeorgiou, P.A. Gimotty, B.L. Weber, and G. Coukos microRNAs exhibit high frequency genomic alterations in human cancer Proc Natl Acad Sci U S A 103 2006 9136 9141
20. H. Clevers Wnt/beta-catenin signaling in development and disease Cell 127 2006 469 480
21. H. Jiang, J. Xia, J. Kang, Y. Ding, and W. Wu Short hairpin RNA targeting beta-catenin suppresses cell proliferation and induces apoptosis in human gastric carcinoma cells Scand J Gastroenterol 44 2009 1452 1462
22. S. Maretto, M. Cordenonsi, S. Dupont, P. Braghetta, V. Broccoli, A.B. Hassan, D. Volpin, G.M. Bressan, and S. Piccolo Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors Proc Natl Acad Sci U S A 100 2003 3299 3304
23. O. Saydam, Y. Shen, T. Wurdinger, O. Senol, E. Boke, M.F. James, B.A. Tannous, A.O. Stemmer-Rachamimov, M. Yi, R.M. Stephens, C. Fraefel, J.F. Gusella, A.M. Krichevsky, and X.O. Breakefield Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway Mol Cell Biol 29 2009 5923 5940
24. L. Ma, J. Young, H. Prabhala, E. Pan, P. Mestdagh, D. Muth, J. Teruya-Feldstein, F. Reinhardt, T.T. Onder, S. Valastyan, F. Westermann, F. Speleman, J. Vandesompele, and R.A. Weinberg miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis Nat Cell Biol 12 2010 247 256
25. W. Liu, Y. Liu, T. Guo, C. Hu, H. Luo, L. Zhang, S. Shi, T. Cai, Y. Ding, and Y. Jin TCF3, a novel positive regulator of osteogenesis, plays a crucial role in miR-17 modulating the diverse effect of canonical Wnt signaling in different microenvironments Cell Death Dis 4 2013 e539
26. D.N. Qin, L. Qian, D.L. Hu, Z.B. Yu, S.P. Han, C. Zhu, X. Wang, and X. Hu Effects of miR-19b overexpression on proliferation, differentiation, apoptosis and Wnt/beta-catenin signaling pathway in P19 cell model of cardiac differentiation in vitro Cell Biochem Biophys 66 2013 709 722
27. M.T. Veeman, D.C. Slusarski, A. Kaykas, S.H. Louie, and R.T. Moon Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements Curr Biol 13 2003 680 685
28. W. Guo, Z. Keckesova, J.L. Donaher, T. Shibue, V. Tischler, F. Reinhardt, S. Itzkovitz, A. Noske, U. Zurrer-Hardi, G. Bell, W.L. Tam, S.A. Mani, A. van Oudenaarden, and R.A. Weinberg Slug and Sox9 cooperatively determine the mammary stem cell state Cell 148 2012 1015 1028
29. T. Reya, A.W. Duncan, L. Ailles, J. Domen, D.C. Scherer, K. Willert, L. Hintz, R. Nusse, and I.L. Weissman A role for Wnt signalling in self-renewal of haematopoietic stem cells Nature 423 2003 409 414
30. F.T. Kolligs, G. Hu, C.V. Dang, and E.R. Fearon Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression Mol Cell Biol 19 1999 5696 5706
31. K.A. O'Donnell, E.A. Wentzel, K.I. Zeller, C.V. Dang, and J.T. Mendell c-Myc-regulated microRNAs modulate E2F1 expression Nature 435 2005 839 843
32. C.J. Bruns, W. Liu, D.W. Davis, R.M. Shaheen, D.J. McConkey, M.R. Wilson, C.D. Bucana, D.J. Hicklin, and L.M. Ellis Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases Cancer 89 2000 488 499
33. D. Ilkovitch, and D.M. Lopez The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression Cancer Res 69 2009 5514 5521
34. X. Xiang, X. Zhuang, S. Ju, S. Zhang, H. Jiang, J. Mu, L. Zhang, D. Miller, W. Grizzle, and H.G. Zhang miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT Oncogene 30 2011 3440 3453
35. S. Naik, and D. Piwnica-Worms Real-time imaging of beta-catenin dynamics in cells and living mice Proc Natl Acad Sci U S A 104 2007 17465 17470
36. H. Kitakata, Y. Nemoto-Sasaki, Y. Takahashi, T. Kondo, M. Mai, and N. Mukaida Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells Cancer Res 62 2002 6682 6687
37. H. Suzuki, D.N. Watkins, K.W. Jair, K.E. Schuebel, S.D. Markowitz, W.D. Chen, T.P. Pretlow, B. Yang, Y. Akiyama, M. Van Engeland, M. Toyota, T. Tokino, Y. Hinoda, K. Imai, J.G. Herman, and S.B. Baylin Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer Nat Genet 36 2004 417 422
38. L. Vermeulen, E.M.F. De Sousa, M. van der Heijden, K. Cameron, J.H. de Jong, T. Borovski, J.B. Tuynman, M. Todaro, C. Merz, H. Rodermond, M.R. Sprick, K. Kemper, D.J. Richel, G. Stassi, and J.P. Medema Wnt activity defines colon cancer stem cells and is regulated by the microenvironment Nat Cell Biol 12 2010 468 476
39. F. Wang, T. Li, B. Zhang, H. Li, Q. Wu, L. Yang, Y. Nie, K. Wu, Y. Shi, and D. Fan MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN Biochem Biophys Res Commun 434 2013 688 694
40. C. Xiao, L. Srinivasan, D.P. Calado, H.C. Patterson, B. Zhang, J. Wang, J.M. Henderson, J.L. Kutok, and K. Rajewsky Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes Nat Immunol 9 2008 405 414
41. J. Cai, H. Guan, L. Fang, Y. Yang, X. Zhu, J. Yuan, J. Wu, and M. Li MicroRNA-374a activates Wnt/beta-catenin signaling to promote breast cancer metastasis J Clin Invest 123 2013 566 579
42. Z.Q. Wu, X.Y. Li, C.Y. Hu, M. Ford, C.G. Kleer, and S.J. Weiss Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression Proc Natl Acad Sci U S A 109 2012 16654 16659
43. N. Yanaihara, N. Caplen, E. Bowman, M. Seike, K. Kumamoto, M. Yi, R.M. Stephens, A. Okamoto, J. Yokota, T. Tanaka, G.A. Calin, C.G. Liu, C.M. Croce, and C.C. Harris Unique microRNA molecular profiles in lung cancer diagnosis and prognosis Cancer Cell 9 2006 189 198
44. C.J. Sarkisian, B.A. Keister, D.B. Stairs, R.B. Boxer, S.E. Moody, and L.A. Chodosh Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis Nat Cell Biol 9 2007 493 505
45. I. Garcia-Cao, M.S. Song, R.M. Hobbs, G. Laurent, C. Giorgi, V.C. de Boer, D. Anastasiou, K. Ito, A.T. Sasaki, L. Rameh, A. Carracedo, M.G. Vander Heiden, L.C. Cantley, P. Pinton, M.C. Haigis, and P.P. Pandolfi Systemic elevation of PTEN induces a tumor-suppressive metabolic state Cell 149 2012 49 62
46. H. Seitz Redefining microRNA targets Curr Biol 19 2009 870 873
47. F.A. Karreth, Y. Tay, D. Perna, U. Ala, S.M. Tan, A.G. Rust, G. DeNicola, K.A. Webster, D. Weiss, P.A. Perez-Mancera, M. Krauthammer, R. Halaban, P. Provero, D.J. Adams, D.A. Tuveson, and P.P. Pandolfi In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma Cell 147 2011 382 395
48. Y. Tay, L. Kats, L. Salmena, D. Weiss, S.M. Tan, U. Ala, F. Karreth, L. Poliseno, P. Provero, F. Di Cunto, J. Lieberman, I. Rigoutsos, and P.P. Pandolfi Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs Cell 147 2011 344 357
49. S. Mukherji, M.S. Ebert, G.X. Zheng, J.S. Tsang, P.A. Sharp, and A. van Oudenaarden MicroRNAs can generate thresholds in target gene expression Nat Genet 43 2011 854 859